Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03052595 (ClinicalTrials.gov)	February 1, 2017	10/2/2017	Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance	Multiple Sclerosis: The Role of Mitochondrial Dysfunction in Insulin Resistance	Multiple Sclerosis;Mitochondrial Alteration	Diagnostic Test: Oral glucose tolerance test;Diagnostic Test: Testing of autonomous nervous system function;Diagnostic Test: Stroop test	Slovak Academy of Sciences	Comenius University	Recruiting	18 Years	45 Years	All	70		Slovakia
2	NCT00062972 (ClinicalTrials.gov)	September 1999	18/6/2003	Improving Memory in Patients With Multiple Sclerosis	Interventions to Improve Memory in Patients With Multiple Sclerosis	Multiple Sclerosis	Drug: donepezil;Drug: glucose	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	U.S. Department of Education	Withdrawn	18 Years	56 Years	All	0	Phase 3	United States